GlassScriptPhysician profile
Mackenzie Selby
NPI 1023710266
$5,001.08
in general payments reported to CMS, 2019-2025
39 companies · $3,743 in 2025
The $3,743 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.08 · 2024: $1,202 · 2025: $3,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,030.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $694.34 | 2025 | |
| Pfizer INC. | $379.50 | 2025 | |
| Sk Life Science, INC. | $248.56 | 2025 | Xcopri |
| Alexion Pharmaceuticals, INC. | $246.44 | 2024-2025 | Ultomiris, Soliris |
| Impel Pharmaceuticals LLC | $223.57 | 2024-2025 | Trudhesa |
| Teva Pharmaceuticals USA, INC. | $204.83 | 2025 | Austedo Xr, Ajovy |
| Amgen INC. | $198.90 | 2024-2025 | Uplizna |
| Vanda Pharmaceuticals INC. | $183.46 | 2025 | Ponvory |
| Genentech USA, INC. | $170.60 | 2025 | Ocrevus Zunovo, Ocrevus |
| Celgene Corporation | $153.28 | 2025 | Zeposia |
| Janssen Biotech, INC. | $112.34 | 2025 | |
| Ucb, INC. | $110.73 | 2025 | Rystiggo |
| Eisai INC. | $102.85 | 2025 | |
| Axsome Therapeutics, INC. | $70.69 | 2025 | Symbravo |
| Tg Therapeutics, INC. | $70.51 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $68.47 | 2025 | Vyvgart Hytrulo |
| Novartis Pharmaceuticals Corporation | $66.02 | 2025 | |
| Biogen, INC. | $64.04 | 2025 | Vumerity, Tysabri |
| Grifols USA, LLC | $63.85 | 2025 | Gamunex-C |
| Jazz Pharmaceuticals INC. | $59.85 | 2025 | |
| Lundbeck LLC | $54.51 | 2025 | Vyepti |
| Neurocrine Biosciences, INC. | $54.37 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $38.29 | 2025 | |
| Lilly USA, LLC | $34.67 | 2025 | Emgality, Reyvow, Amyvid |
| Ge Healthcare | $33.97 | 2024 | |
| Janssen Scientific Affairs, LLC | $32.09 | 2025 | |
| Boston Scientific Corporation | $31.66 | 2025 | Accolade Sr |
| Ani Pharmaceuticals, INC. | $28.15 | 2025 | Purified Cortrophin Gel |
| Ipsen Biopharmaceuticals, INC | $26.09 | 2025 | Dysport |
| Supernus Pharmaceuticals, INC. | $24.90 | 2025 | Qelbree |
| Ns Pharma, INC. | $24.39 | 2025 | Viltepso |
| Neurelis, INC. | $23.50 | 2025 | Valtoco |
| Globus Medical, INC. | $21.73 | 2025 | Senza |
| Acadia Pharmaceuticals INC | $21.27 | 2025 | Nuplazid |
| Tanabe Pharma America, INC. | $19.53 | 2025 | Radicava |
| Csl Behring | $17.81 | 2025 | Hizentra |
| Alnylam Pharmaceuticals INC. | $17.80 | 2025 | Onpattro |
| Tonix Medicines, INC. | $16.46 | 2025 | Zembrace Symtouch |
| Sandoz INC. | $16.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Selby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.